The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

New data from the CDC and other leading health agencies shows a number of health markers are beginning to improve in the US - ...

The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...

An obesity expert weighs in on intriguing new data and new drugs that hold promise in the battle against a stubborn problem.

Discover how new weight loss drugs from Novo Nordisk (NVO) and Eli Lilly (LLY) may have helped reduce U.S. obesity rates.

Newly released data shows that the U.S. may have reached peak obesity in 2020 — and the timing unsurprisingly coincides with ...

One creator suggests that lemon balm helps with stress, insomnia, alertness, and that it’s been found to potentially help ...

No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric ...

Across the European Union, there is a growing diversification of illegal drugs and increasing violence linked to organised crime. But there are also new solutions and enhanced forms of cooperation ...

WeightWatchers has struggled against competition from new “GLP-1” weight loss drugs such as Eli Lilly ... 97 per cent of their value since mid-2021. Thilo Semmelbauer, chair of the company ...

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and. Drug Administration. Cobenfy (xanomeline/trospium chloride ...

Share on Pinterest Bariatric surgery may be better for preserving kidney function in people with diabetes and obesity than GLP-1 drugs. Image credit: Ruben Earth/Getty Images. In a new study ...